# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001367644-23-000075
Filing Date
2023-03-23
Accepted
2023-03-23 17:25:59
Documents
19
Period of Report
2023-03-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ebs-20230323.htm iXBRL | 8-K | 45683
2 | EX-10 | exc_compmins2-9x23v1x202.htm | EX-10 | 17977
6 |  | exc_compmins2-9x23v1x202001.jpg | GRAPHIC | 250792
7 |  | exc_compmins2-9x23v1x202002.jpg | GRAPHIC | 252171
8 |  | exc_compmins2-9x23v1x202003.jpg | GRAPHIC | 170809
9 |  | exc_compmins2-9x23v1x202004.jpg | GRAPHIC | 186041
10 |  | exc_compmins2-9x23v1x202005.jpg | GRAPHIC | 248251
11 |  | exc_compmins2-9x23v1x202006.jpg | GRAPHIC | 149631
| Complete submission text file | 0001367644-23-000075.txt |  | 1938987

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ebs-20230323.xsd | EX-101.SCH | 1965
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ebs-20230323_lab.xml | EX-101.LAB | 25154
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ebs-20230323_pre.xml | EX-101.PRE | 13100
13 | EXTRACTED XBRL INSTANCE DOCUMENT | ebs-20230323_htm.xml | XML | 4436

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 23757165
SIC: 2834 Pharmaceutical Preparations